We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.45%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$620M
AUM Growth
-$22.5M
(-3.5%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
7
Increased
6
Reduced
34
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XENT
Intersect ENT, Inc
XENT
|
+$8.69M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$5.06M |
| 3 |
Veracyte
VCYT
|
+$3.37M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
+$2.38M |
| 5 |
CLLS
Cellectis
CLLS
|
+$2.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$57.3M |
| 2 |
NeoGenomics
NEO
|
+$20.2M |
| 3 |
AtriCure
ATRC
|
+$13M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$11.9M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$9.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.6% |
| 2 | Communication Services | 3.41% |
| 3 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$618B
| $302K | 0.05% |
2,183
| – | – |
|
52
Sanofi
SNY
$103B
| $300K | 0.05% |
6,720
| – | – |
|
53
Amgen
AMGN
$208B
| $229K | 0.04% |
1,105
| – | – |
|
54
Revvity
RVTY
$12.6B
| $221K | 0.04% |
+2,270
| New | +$195K |
|
55
Elevance Health
ELV
$81.5B
| $220K | 0.04% |
+803
| New | +$208K |
|
56
HCA Healthcare
HCA
$87.2B
| $210K | 0.03% |
+1,513
| New | +$188K |
|
57
Teleflex
TFX
$6.05B
| $208K | 0.03% |
783
| – | – |
|
|
HRC
58
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $202K | 0.03% |
+2,144
| New | +$201K |
|
|
STRM
59
DELISTED
Streamline Health Solutions
STRM
| $47K | 0.01% |
2,647
-112,297
| -98% | -$2.15M |
|
60
IRIDEX
IRIX
$14.3M
| – | – |
-198,581
| Closed | -$1.38M |
|
|
NVRO
61
DELISTED
NEVRO CORP.
NVRO
| – | – |
-116,224
| Closed | -$9.28M |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| – | – |
-14,742
| Closed | -$1.17M |
|
|
XLVS
63
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| – | – |
-17,285
| Closed | -$2.22M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, First Light Asset Management held 63 positions worth $620M, down 3.5% from $642M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
First Light Asset Management withdrew a net $102M in Q3 2018, closing 4 positions and reducing 34 holdings. Its most notable exit was NEVRO CORP., an estimated $9.28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Communication Services and Energy.
Against the trend, First Light Asset Management opened a new position in Invesco S&P SmallCap Health Care ETF worth $2.43M.
- First Light Asset Management's largest Q3 2018 buy was Invesco S&P SmallCap Health Care ETF: 51,855 shares worth $2.43M.
- First Light Asset Management added most to Intersect ENT, Inc in Q3 2018, an estimated $8.69M increase.
- First Light Asset Management's biggest Q3 2018 reduction was Tandem Diabetes Care, cutting an estimated $57.3M.
- First Light Asset Management fully exited NEVRO CORP. in Q3 2018, selling an estimated $9.28M.
- First Light Asset Management's ten largest holdings make up 57% of its $620M portfolio in Q3 2018.
- First Light Asset Management opened 7 new positions and closed 4 in Q3 2018.
- First Light Asset Management's portfolio value fell 3.5% quarter-over-quarter to $620M.
Based on First Light Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.